271 related articles for article (PubMed ID: 24342806)
1. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation.
Morimoto K; Shirata N; Taketomi Y; Tsuchiya S; Segi-Nishida E; Inazumi T; Kabashima K; Tanaka S; Murakami M; Narumiya S; Sugimoto Y
J Immunol; 2014 Feb; 192(3):1130-7. PubMed ID: 24342806
[TBL] [Abstract][Full Text] [Related]
2. Co-Stimulation of Purinergic P2X4 and Prostanoid EP3 Receptors Triggers Synergistic Degranulation in Murine Mast Cells.
Yoshida K; Tajima M; Nagano T; Obayashi K; Ito M; Yamamoto K; Matsuoka I
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627451
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
[TBL] [Abstract][Full Text] [Related]
5. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production.
Nguyen M; Solle M; Audoly LP; Tilley SL; Stock JL; McNeish JD; Coffman TM; Dombrowicz D; Koller BH
J Immunol; 2002 Oct; 169(8):4586-93. PubMed ID: 12370397
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
7. Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix.
Sakanaka M; Tanaka S; Sugimoto Y; Ichikawa A
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1427-33. PubMed ID: 18815228
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema.
Claudino RF; Kassuya CA; Ferreira J; Calixto JB
J Pharmacol Exp Ther; 2006 Aug; 318(2):611-8. PubMed ID: 16644903
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
Kobayashi K; Murata T; Hori M; Ozaki H
Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.
Gomi K; Zhu FG; Marshall JS
J Immunol; 2000 Dec; 165(11):6545-52. PubMed ID: 11086097
[TBL] [Abstract][Full Text] [Related]
11. Intravital microscopic studies on acute mast cell-dependent inflammation.
Raud J
Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
[TBL] [Abstract][Full Text] [Related]
12. Age-induced reprogramming of mast cell degranulation.
Nguyen M; Pace AJ; Koller BH
J Immunol; 2005 Nov; 175(9):5701-7. PubMed ID: 16237060
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism.
Marshall JS; Gomi K; Blennerhassett MG; Bienenstock J
J Immunol; 1999 Apr; 162(7):4271-6. PubMed ID: 10201958
[TBL] [Abstract][Full Text] [Related]
14. PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells.
Kovarova M; Koller BH
PLoS One; 2014; 9(7):e102948. PubMed ID: 25054560
[TBL] [Abstract][Full Text] [Related]
15. Distinct PGE2-responder and non-responder phenotypes in human mast cell populations: "all or nothing" enhancement of antigen-dependent mediator release.
Kuehn HS; Jung MY; Beaven MA; Metcalfe DD; Gilfillan AM
Immunol Lett; 2011 Dec; 141(1):45-54. PubMed ID: 21798286
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
Chung KF
Sci STKE; 2005 Sep; 2005(303):pe47. PubMed ID: 16189372
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.
Kawahara K; Hohjoh H; Inazumi T; Tsuchiya S; Sugimoto Y
Biochim Biophys Acta; 2015 Apr; 1851(4):414-21. PubMed ID: 25038274
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles of the PGE2 -EP receptor signal in vascular permeability.
Omori K; Kida T; Hori M; Ozaki H; Murata T
Br J Pharmacol; 2014 Nov; 171(21):4879-89. PubMed ID: 24923772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
